Cogent Biosciences Inc.

NASDAQ: COGT · Real-Time Price · USD
11.88
0.17 (1.45%)
At close: Aug 15, 2025, 3:59 PM
11.89
0.08%
After-hours: Aug 15, 2025, 05:29 PM EDT

Cogent Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-255.86M -192.41M -140.24M -72.27M
Depreciation & Amortization
4.35M 3.59M 5.88M 147K
Stock-Based Compensation
39.74M 30.62M 18.37M 11.69M
Other Working Capital
10.24M 6.63M -1.61M -731K
Other Non-Cash Items
-7.62M -6.87M -3.39M -343K
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
11.6M 11.44M 751K 2.02M
Operating Cash Flow
-207.79M -153.62M -118.64M -58.76M
Capital Expenditures
-573K -2.8M -6.86M -1.72M
Cash Acquisitions
n/a n/a 117.86K n/a
Purchase of Investments
-255.6M -348.8M -177.85M n/a
Sales Maturities Of Investments
294.45M 253.78M 60M n/a
Other Investing Acitivies
n/a n/a -117.86K n/a
Investing Cash Flow
38.28M -97.82M -124.72M -1.72M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
n/a n/a 1.61M -30K
Financial Cash Flow
214.45M 163.54M 163.56M 37.98M
Net Cash Flow
44.94M -87.91M -79.8M -22.51M
Free Cash Flow
-208.36M -156.42M -125.5M -60.48M